Company Overview of Xantos AG
Xantos AG, a functional biology and drug discovery company, focuses on the identification and validation of disease relevant human genes. It develops biopharmaceuticals in the areas of cancer and metabolic diseases, as well as focuses on the development of therapeutics based on secreted proteins involved in angiogenesis of cancer cells. It offers its technology, the human cDNA collections, libraries, and functional cell assay systems on a fee-for-service basis. The company’s XantoScreen robotic platform is used for various functional applications, such as molecular drug profiling, target/pathway profiling, target and protein identification, and lead identification. The XantoScreen also enabl...
Founded in 1999
49 89 899 59 400
49 89 899 59 420
Key Executives for Xantos AG
Co-Founder and Chief Executive Officer
Scientific Founder and Member of Scientific Advisory Board
Manager of Human Resources
Compensation as of Fiscal Year 2015.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries